Align Technology to Announce Q4 2024 Results Amid Digital Dentistry Innovations
- Align Technology will release its Q4 and 2024 financial results on February 5, 2025, at 4:00 p.m. ET.
- The company has treated around 18.9 million patients with its Invisalign System, highlighting its market leadership.
- Align focuses on innovation in digital dentistry, serving over 271,000 doctors and tapping into a global market of 600 million.
Align Technology Plans Financial Results Release Amidst Innovations in Digital Dentistry
Align Technology, Inc. is set to release its fourth quarter and 2024 financial results on February 5, 2025, at 4:00 p.m. ET, showcasing its commitment to transparency and investor engagement. This announcement comes as Align continues to solidify its position as a leader in the medical device industry, particularly in digital orthodontics and restorative workflows. Following the financial release, the company will conduct a conference call at 4:30 p.m. ET to discuss the results, which will be accessible via a live audio webcast. The archived version of this call will be available for a month, allowing investors and stakeholders to review the insights shared.
Align Technology, known for its flagship products like the Invisalign® System and iTero™ intraoral scanners, has been at the forefront of transforming dental practices through innovative technology. Over its 27-year history, the company has treated around 18.9 million patients with its Invisalign System, a clear aligner solution that has revolutionized orthodontic treatment. The company serves a robust network of over 271,000 doctor customers, indicating a strong demand for its products. Align’s integrated suite of technologies, branded as the Align™ Digital Platform, aims to further enhance efficiencies in the practice of dentistry, ultimately improving patient outcomes and operational workflows for dental professionals.
The potential for growth in the digital dentistry market remains significant, with Align tapping into a global consumer base of approximately 600 million. This expansive market opportunity underscores Align's strategic focus on innovation and development within the industry. The company has also announced tentative dates for its fiscal 2025 earnings releases, with Q1 results expected on April 30, Q2 on July 30, and Q3 on October 29. This proactive approach in financial reporting reflects Align's ongoing commitment to stakeholder engagement and transparency.
In addition to its upcoming financial disclosures, Align Technology emphasizes its dedication to improving patient care through advanced digital solutions. By continuously enhancing its product offerings, including the Invisalign System and iTero scanners, Align positions itself as a frontrunner in the evolution of digital dentistry. With a robust framework for innovation and a substantial market presence, Align Technology remains poised to lead the future of orthodontics and restorative practices.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…